In this podcast endocrine expert David C. Lieb, MD, FACP, FACE, interviews our AACE 2023 award-winning plenary speakers, Elizabeth N. Pearce, MD, MSc, FACE, Irl Hirsch, MD, and Richard J. Auchus, MD, PhD, FACE, about the latest advancements in thyroid disease, diabetes, and adrenal disease. Key topics include iodine deficiency, adjusting thyroid medication doses, the future of insulin therapy, GMI compared to A1C levels, screening for primary aldosteronism, Cushing's syndrome, adrenal steroid profiling, and more. 

There is varying knowledge among members of the endocrine care team about the vaccines AACE recommends for persons with diabetes that are included in the updated 2022 AACE Diabetes Guideline. In this podcast endocrine expert Vin Tangpricha, MD, PhD, interviews internationally known clinician, epidemiologist, and Interim Dean of Emory University School of Medicine, Carlos del Rio, MD, about the importance of vaccines, how vaccines are made, developed, and approved, and how to use this information to address patients’ questions or hesitancy towards vaccines.

Join endocrine experts S. Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE, Susan L. Samson, MD, PhD, FRCPC, FACE, and Vin Tangpricha, MD, FACE, as they discuss the 2022 AACE diabetes clinical practice guideline featuring 170 updated and new evidence-based recommendations for the care and management of people with or at risk for diabetes mellitus. Key topics include how to use the guideline in your practice, new content developed on hypoglycemia, secondary diabetes approaches, supplements, social determinants of health, and more. Plus, get an inside sneak peek into the development of a diabetes care algorithm coming soon. Visit https://www.endocrinepractice.org/article/S1530-891X(22)00576-6/fulltext to view the full guideline published in the October 2022 issue of Endocrine Practice.

Join endocrine experts S. Sethu K. Reddy, MD, MBA, FRCPC, FACP, MACE, Susan L. Samson, MD, PhD, FRCPC, FACE, and Vin Tangpricha, MD, FACE, as they discuss the 2022 AACE diabetes clinical practice guideline featuring 170 updated and new evidence-based recommendations for the care and management of people with or at risk for diabetes mellitus. Key topics include how to use the guideline in your practice, new content developed on hypoglycemia, secondary diabetes approaches, supplements, social determinants of health, and more. Plus, get an inside sneak peek into the development of a diabetes care algorithm coming soon. Visit https://www.endocrinepractice.org/article/S1530-891X(22)00576-6/fulltext to view the full guideline published in the October 2022 issue of Endocrine Practice.

Listen to endocrine experts, Vinni Makin, MD, Joumana Chaiban, MD, and Ricardo Correa, MD, share their personal experiences about how they obtained a visa as international medical graduates and transitioned to practicing medicine in the United States. Key topics include visa requirements, how to apply for a visa, and the benefits of a mentorship program once you transition to the U.S.

For persons with diabetes, vaccinations have been shown to help them from contracting and experiencing more severe outcomes from preventable illnesses, such as influenza and Covid-19.

It is important for the endocrine care team to learn practical strategies for increasing vaccination rates for their patients with diabetes. Join endocrine experts Geetha Gopalakrishnan, MD, FACE and David C. Lieb, MD, FACE as they share their perspectives and experiences on advancing immunizations by using the CDC’s Standards for Adult Immunization Practice and working to build a practice culture of vaccine confidence. Visit www.AACE.com/immunization for additional education and resources.

Adrenal insufficiency is a life-threatening condition but diagnosis is typically delayed. The initial presentation is often non-specific and physician awareness must be improved to avoid adrenal crisis. Join endocrine experts Shobana Athimulam, MD, Clinical Assistant Professor, Division of Endocrinology, Bone and Mineral Disorders in Henry Ford Health, Detroit, Michigan, and Lucinda Gruber, MD, Assistant Professor, Division of Endocrinology, Diabetes, Metabolism and Nutrition at Mayo Clinic in Rochester, Minnesota, as they discuss the etiology and clinical presentation of patients with adrenal insufficiency, challenges in making the diagnosis, role of dynamic testing and management of special patient populations.

Nonalcoholic fatty liver disease (NAFLD) is a major public health problem that will only worsen in the future, as it is closely linked to the epidemics of obesity and type 2 diabetes mellitus. Given this link, endocrinologists and primary care physicians are in an ideal position to identify persons at risk to prevent the development of cirrhosis and comorbidities. Join endocrine expert Vin Tangpricha, M.D., Ph.D., as he interviews AACE Co-Chairs, guideline task force experts, Kenneth Cusi, MD, FACP, FACE, and Scott D. Isaacs, MD, FACP, FACE, about the newly released 2022 clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease, published in the May 2022 issue of Endocrine Practice (https://www.endocrinepractice.org/article/S1530-891X(22)00090-8/fulltext).

Having a high level of triglycerides in your blood can increase your risk of heart disease. Join endocrine experts Eliot A. Brinton, MD, FAHA, FNLA, FACE, President of Utah Lipid Center, and Past President, of the American Board of Clinical Lipidology, and Betul Hatipoglu MD, Professor of Medicine at CWRU School of Medicine, and Medical Director for Diabetes & Obesity Center at University Hospital Cleveland Medical Center, as they discuss clinical pearls about different lipid tests, and challenging cases of triglycerides such as pregnancy. 

The landmark Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT®) was a global outcomes study designed to assess the cardioprotective efficacy and safety of VASCEPA® (icosapent ethyl) as an add-on to statin therapy in reducing major cardiovascular (CV) events in a high-risk patient population. Join endocrine experts Eliot A. Brinton, MD, FAHA, FNLA, FACE, President of Utah Lipid Center, and Past President, of the American Board of Clinical Lipidology, and Betul Hatipoglu MD, Professor of Medicine at CWRU School of Medicine, and Medical Director for Diabetes & Obesity Center at University Hospital Cleveland Medical Center, to learn about the results of the REDUCE-IT® trial and new developments in CV prevention.